Abstract
The development of technetium based diagnostic imaging agents continues to remain a high impact area in nuclear medicine research. In particular, the single photon emitting radionuclide 99mTc comprises the majority of diagnostic imaging scans performed daily at hospitals and clinics. While research with 99mTc has been active for several decades, this review focuses on the overview of recent developments and current trends surrounding 99mTc applications. Discussion includes the fundamental design of 99mTc complexes, new labeling methodologies, and development of molecular probes for the next generation of in vivo diagnostic imaging agents.
Keywords: Technetium, complexes, radiopharmaceuticals, nuclear medicine, SPECT, Probe, Molecular Imaging, TC CHEMISTRY, PEPTIDE BASED Tc AGENTS, NANOPARTICLES
Current Organic Synthesis
Title: Recent Advances in the Probe Development of Technetium-99m Molecular Imaging Agents
Volume: 8 Issue: 4
Author(s): Paul D. Benny and Adam L. Moore
Affiliation:
Keywords: Technetium, complexes, radiopharmaceuticals, nuclear medicine, SPECT, Probe, Molecular Imaging, TC CHEMISTRY, PEPTIDE BASED Tc AGENTS, NANOPARTICLES
Abstract: The development of technetium based diagnostic imaging agents continues to remain a high impact area in nuclear medicine research. In particular, the single photon emitting radionuclide 99mTc comprises the majority of diagnostic imaging scans performed daily at hospitals and clinics. While research with 99mTc has been active for several decades, this review focuses on the overview of recent developments and current trends surrounding 99mTc applications. Discussion includes the fundamental design of 99mTc complexes, new labeling methodologies, and development of molecular probes for the next generation of in vivo diagnostic imaging agents.
Export Options
About this article
Cite this article as:
D. Benny Paul and L. Moore Adam, Recent Advances in the Probe Development of Technetium-99m Molecular Imaging Agents, Current Organic Synthesis 2011; 8 (4) . https://dx.doi.org/10.2174/157017911796117214
DOI https://dx.doi.org/10.2174/157017911796117214 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MicroRNAs Patents: The Road From Bench to Bedsides for Cancer Treatment
Recent Patents on DNA & Gene Sequences In Vitro and In Vivo Investigations into the Carbene Gold Chloride and Thioglucoside Anticancer Drug Candidates NHC-AuCl and NHC-AuSR
Letters in Drug Design & Discovery Dual Induction of Mitochondrial Apoptosis and Senescence in Chronic Myelogenous Leukemia by Myrtucommulone A
Anti-Cancer Agents in Medicinal Chemistry AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer’s Disease
Current Neuropharmacology Hypoxia-inducible Factor (HIF) in Hormone Signaling During Health and Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry The Effects of Soy Isoflavones in Postmenopausal Women: Clinical Review
Current Drug Therapy The Exploitation of Toll-like Receptor 3 Signaling in Cancer Therapy
Current Pharmaceutical Design Fused Xanthone Derivatives as Antiproliferative Agents
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: Vaccines)
Recent Patents on Inflammation & Allergy Drug Discovery Artificial Virus as Trump-card to Resolve Exigencies in Targeted Gene Delivery
Mini-Reviews in Medicinal Chemistry Staphylococcus aureus: The Toxic Presence of a Pathogen Extraordinaire
Current Medicinal Chemistry Adverse Reactions to Fluoroquinolones. An Overview on Mechanistic Aspects
Current Medicinal Chemistry Plumbagin Nanoparticles Induce Dose and pH Dependent Toxicity on Prostate Cancer Cells.
Current Drug Delivery An Update on Circumventing Multidrug Resistance in Cancer by Targeting P-Glycoprotein
Current Cancer Drug Targets Lymphatic Endothelial Cells, Inflammatory Lymphangiogenesis, and Prospective Players
Current Medicinal Chemistry Senescence of the Brain: Focus on Cognitive Kinases
Current Pharmaceutical Design Detection of Liver Metastases with Contrast Enhanced Ultrasonography
Current Medical Imaging Therapeutic Potential of Hammerhead Ribozymes in the Treatment of Hyper-Proliferative Diseases
Current Pharmaceutical Biotechnology Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging
Current Cancer Drug Targets Clinical Pharmacogenetics in Oncology: the Paradigm of Molecular Targeted Therapies
Current Pharmaceutical Design